ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $112,893,000 | -25.1% | 2,792,995 | +6.7% | 0.03% | -19.4% |
| Q2 2015 | $150,664,000 | -48.5% | 2,617,963 | -43.0% | 0.04% | -48.6% |
| Q1 2015 | $292,506,000 | +6.0% | 4,594,099 | +2.7% | 0.07% | +2.9% |
| Q4 2014 | $276,068,000 | +72.5% | 4,471,458 | +8.5% | 0.07% | +51.1% |
| Q3 2014 | $159,997,000 | +12.4% | 4,120,458 | -0.3% | 0.04% | +12.5% |
| Q2 2014 | $142,406,000 | -24.8% | 4,133,698 | -5.7% | 0.04% | -28.6% |
| Q1 2014 | $189,393,000 | +13.0% | 4,383,087 | +4.2% | 0.06% | +9.8% |
| Q4 2013 | $167,636,000 | +4.5% | 4,207,732 | -1.6% | 0.05% | -5.6% |
| Q3 2013 | $160,446,000 | +62.5% | 4,273,989 | +16.3% | 0.05% | +50.0% |
| Q2 2013 | $98,763,000 | – | 3,675,568 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |